KL and diabetic kidney disease: Thus, considering Klotho as an antagonist for the Wnt pathway, as well as the previously discussed data, it can be proposed that the downregulation of this protein in CKD might contribute to the excessive activation of Wnt/β-catenin signaling, which is associated with the development of renal conditions, such as DKD.